


Technical Sentiment Analysis for Franklin Genomic Advancements ETF (HELX). As of 2026-04-15, Franklin Genomic Advancements ETF (HELX) is exhibiting a Buy technical sentiment. Our proprietary analysis, which aggregates 13 technical signals, shows that 8 indicators are flashing buy, while 5 are indicating sell.
Momentum Indicators: RSI, MACD & Overbought/Oversold Status. Currently, the Relative Strength Index (RSI) for HELX stands at 58.8, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.16, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 89.18 and the Commodity Channel Index (CCI) at 134.31 further confirm a 1.41 outlook for the ETF.
Support, Resistance & Moving Averages. From a structural perspective, HELX is trading above its 60-day moving average of $34.23 and above its 200-day long-term moving average of $33.06. Key price levels to watch include the immediate resistance at $34.6 and strong support at $32.65. A break above $34.6 could signal a bull continuation, while falling below $32.65 may test the next Fibonacci floor at $31.7.
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 30.69 | 31.7 | 32.65 | 33.65 | 34.6 | 35.61 | 36.56 |
| Fibonacci | 31.7 | 32.45 | 32.91 | 33.65 | 34.4 | 34.86 | 35.61 |
2026-04-15
| Name | Value |
|---|---|
| Relative Strength Index (RSI) | 58.8 |
| Stochastic Oscillator | 89.18 |
| Stochastic RSI | 76.23 |
| Commodity Channel Index (CCI) | 134.31 |
| Awesome Oscillator | 0.71 |
| Momentum | 1.41 |
| MACD | 0.16 |
2026-04-15
| Period | Simple | Signal |
|---|---|---|
| 5-Day | 33.74 | Buy |
| 10-Day | 33.6 | Buy |
| 20-Day | 32.83 | Buy |
| 60-Day | 34.23 | Sell |
| 200-Day | 33.06 | Buy |
| 250-Day | 31.78 | Buy |